299 related articles for article (PubMed ID: 28416489)
21. Directly interact with Keap1 and LPS is involved in the anti-inflammatory mechanisms of (-)-epicatechin-3-gallate in LPS-induced macrophages and endotoxemia.
Chiou YS; Huang Q; Ho CT; Wang YJ; Pan MH
Free Radic Biol Med; 2016 May; 94():1-16. PubMed ID: 26878775
[TBL] [Abstract][Full Text] [Related]
22. Nrf2-Keap1 signaling in oxidative and reductive stress.
Bellezza I; Giambanco I; Minelli A; Donato R
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):721-733. PubMed ID: 29499228
[TBL] [Abstract][Full Text] [Related]
23. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
[TBL] [Abstract][Full Text] [Related]
24. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.
Sun Z; Zhang S; Chan JY; Zhang DD
Mol Cell Biol; 2007 Sep; 27(18):6334-49. PubMed ID: 17636022
[TBL] [Abstract][Full Text] [Related]
25. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
[TBL] [Abstract][Full Text] [Related]
26. Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma.
Arora M; Kumari S; Kadian L; Anupa G; Singh J; Kumar A; Verma D; Pramanik R; Kumar S; Yadav R; Chopra A; Chauhan SS
Biosci Rep; 2023 Sep; 43(9):. PubMed ID: 37531267
[TBL] [Abstract][Full Text] [Related]
27. miRNA-141 attenuates UV-induced oxidative stress via activating Keap1-Nrf2 signaling in human retinal pigment epithelium cells and retinal ganglion cells.
Cheng LB; Li KR; Yi N; Li XM; Wang F; Xue B; Pan YS; Yao J; Jiang Q; Wu ZF
Oncotarget; 2017 Feb; 8(8):13186-13194. PubMed ID: 28061435
[TBL] [Abstract][Full Text] [Related]
28. The role of Nrf2 in oxidative stress-induced endothelial injuries.
Chen B; Lu Y; Chen Y; Cheng J
J Endocrinol; 2015 Jun; 225(3):R83-99. PubMed ID: 25918130
[TBL] [Abstract][Full Text] [Related]
29. FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding.
Cheng KC; Lin RJ; Cheng JY; Wang SH; Yu JC; Wu JC; Liang YJ; Hsu HM; Yu J; Yu AL
EBioMedicine; 2019 Jul; 45():25-38. PubMed ID: 31262713
[TBL] [Abstract][Full Text] [Related]
30. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
32. Dipeptidyl Peptidase 3 Activity as a Promising Biomarker of Bone Fragility in Postmenopausal Women.
Menale C; Tabacco G; Naciu AM; Schiavone ML; Cannata F; Morenghi E; Sobacchi C; Palermo A
Molecules; 2022 Jun; 27(12):. PubMed ID: 35745051
[TBL] [Abstract][Full Text] [Related]
33. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
[TBL] [Abstract][Full Text] [Related]
34. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
Yang SP; Yang XZ; Cao GP
Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
[TBL] [Abstract][Full Text] [Related]
35. Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells.
Wu J; Williams D; Walter GA; Thompson WE; Sidell N
Exp Cell Res; 2014 Nov; 328(2):351-60. PubMed ID: 25172557
[TBL] [Abstract][Full Text] [Related]
36. Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway.
Heyninck K; Sabbe L; Chirumamilla CS; Szarc Vel Szic K; Vander Veken P; Lemmens KJA; Lahtela-Kakkonen M; Naulaerts S; Op de Beeck K; Laukens K; Van Camp G; Weseler AR; Bast A; Haenen GRMM; Haegeman G; Vanden Berghe W
Biochem Pharmacol; 2016 Jun; 109():48-61. PubMed ID: 27045103
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression.
Kabaria S; Choi DC; Chaudhuri AD; Jain MR; Li H; Junn E
Free Radic Biol Med; 2015 Dec; 89():548-56. PubMed ID: 26453926
[TBL] [Abstract][Full Text] [Related]
38. Prognosis of hormone-dependent breast cancer seems to be influenced by KEAP1, NRF2 and GSTM1 genetic polymorphisms.
Almeida M; Soares M; Ramalhinho AC; Moutinho JF; Breitenfeld L
Mol Biol Rep; 2019 Jun; 46(3):3213-3224. PubMed ID: 30941643
[TBL] [Abstract][Full Text] [Related]
39. Mathematical modeling reveals quantitative properties of KEAP1-NRF2 signaling.
Liu S; Pi J; Zhang Q
Redox Biol; 2021 Nov; 47():102139. PubMed ID: 34600335
[TBL] [Abstract][Full Text] [Related]
40. Role of the Keap1-Nrf2 pathway in cancer.
Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
